FDA Inspection
Allergan Sales, LLCAllergan Sales, LLC – FDA Inspection, Nov 7, 2025
Record Details
This FDA Inspection record concerns Allergan Sales, LLC, with an inspection on November 7, 2025, issued by the Los Angeles District Office, covering human drugs.
View Company Profile
ID · 451dddd4-4210-4c54-869d-9da4fa3dc439
Inspection Facts
- Inspection number
- 1285134
- FDA center
- Human Drugs
Other FDA inspections of Allergan Sales, LLC
14| Date | Classification | Office | Project area |
|---|---|---|---|
| September 19, 2025 | Not classified | Los Angeles District Office | |
| October 26, 2023 | Not classified | Los Angeles District Office | |
| July 28, 2023 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 22, 2019 | NAI | Center for Devices and Radiological Health | Bioresearch Monitoring |
| October 19, 2016 | NAI | Center for Devices and Radiological Health | Compliance: Devices |
Other documents for Allergan Sales, LLC
- FDA Inspection 1276207 - 2025-09-19
- FDA Inspection 1226167 - 2023-10-26
- FDA Inspection 1217963 - 2023-07-28
- FDA Inspection 1077891 - 2019-01-22
- FDA Inspection 991910 - 2016-10-19
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.